Gabapentin: the first preemptive anti-hyperalgesic for opioid withdrawal hyperalgesia?
Gustorff
Burkhard
B
Kozek-Langenecker
Sibylle
S
Kress
Hans Georg
HG
D000085:Acetates / Q000627:therapeutic use*; D000588:Amines; D000700:Analgesics / Q000627:therapeutic use*; D000701:Analgesics, Opioid / Q000009:adverse effects* / Q000627:therapeutic use; D003509:Cyclohexanecarboxylic Acids; D005260:Female; D000077206:Gabapentin; D006801:Humans; D006930:Hyperalgesia / Q000209:etiology / Q000517:prevention & control*; D015409:Mastectomy, Radical; D009020:Morphine / Q000009:adverse effects* / Q000627:therapeutic use; D010149:Postoperative Pain / Q000188:drug therapy; D013375:Substance Withdrawal Syndrome / Q000517:prevention & control*; D005680:gamma-Aminobutyric Acid
D000085:Acetates; D000588:Amines; D000700:Analgesics; D000701:Analgesics, Opioid; D003509:Cyclohexanecarboxylic Acids; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin; D009020:Morphine